Muscle WeaknessNCT06884371
Lumbar Paraspinal Muscle Fatty Infilteration
An observational study of Muscle Weakness, run by Noha Khaled Shoukry at 1 site in Egypt.
Trial summary
Introducing a unique clinical case of limb-girdle muscular dystrophy associated with LBP that was initially misdiagnosed as non-specific LBP Read more about this study
- Who is it for?
- Ages 20 to 40 years, men only
- Conditions the study is for
- Muscle Weakness
- What is being tested?
- physical therapy
- How many people
- 1 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2025to 28 Feb 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Men only
- No healthy volunteers
- Adult
Study population: A 22-year-old man who used to work eight hours a day sitting for a long time in an office
Who may be able to join
- experiencing lower back stiffness and a dull back pain
Who cannot join
- diabetes, heart disease, or muscle disease. any history of previous falls, accidents, surgeries, hospitalizations, and he denied any significant past illnesses, or allergies.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Is a Complete Fatty Infilteration of Lumbar Paraspinal Muscles an Indicator to a Serious Pathology: A Case Report
Introducing a unique clinical case of limb-girdle muscular dystrophy associated with LBP that was initially misdiagnosed as non-specific LBP
Read the detailed description
This case report describes the history, examination findings, and clinical reasoning used for a patient suffering from LBP as a chief complaint. A new sign appeared in MRI, which prompted the author to change the diagnosis process from lower back pain to a mysterious neurological disease, The MRI revealed widespread fat deposit in the lumbar paraspinal muscles. This MRI sign prompted the authors to do more lab investigation, showing a notably elevated level of creatinine phosphokinase (906 u/L). Further clinical examination revealed proximal muscle weakness, winging of scapula and Bilateral LMN facial palsy. Therefore, the patient was ultimately directed to a neurologist who confirmed the diagnosis of limb-girdle muscular dystrophy
- Conditions
- Muscle Weakness
- Being tested
- physical therapy
- Medical subject headings
- Muscle Weakness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
physical therapyOther
ultrasound and TENS for the back
What is being measured
The primary outcome is the main question the study is designed to answer.
An MRI of the lumbar spine
Measured: one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2025
- Study start1 Jan 2025
- Primary completion28 Feb 2025
- Study completion28 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Muscle WeaknessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 1 participants (actual)
Sponsor and investigators
- Lead sponsor
- Noha Khaled Shoukry
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Noha Khaled Shoukry, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06884371
- Sponsor's protocol ID
- cairo university PT 1
- Status last verified
- Mar 2025
- First submitted
- 13 Mar 2025
- Last updated
- 19 Mar 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 19 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is a Complete Fatty Infilteration of Lumbar Paraspinal Muscles an Indicator to a Serious Pathology: A Case Report
- ClinicalTrials.gov ID
- NCT06884371
- Acronym / sponsor ID
- cairo university PT 1
- Conditions
- Muscle Weakness
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1 participants (actual)
- Lead sponsor
- Noha Khaled ShoukryUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 28 Feb 2025 (actual)
- Study completion
- 28 Feb 2025 (actual)
- First posted
- 19 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introducing a unique clinical case of limb-girdle muscular dystrophy associated with LBP that was initially misdiagnosed as non-specific LBP
Detailed description
This case report describes the history, examination findings, and clinical reasoning used for a patient suffering from LBP as a chief complaint. A new sign appeared in MRI, which prompted the author to change the diagnosis process from lower back pain to a mysterious neurological disease, The MRI revealed widespread fat deposit in the lumbar paraspinal muscles. This MRI sign prompted the authors to do more lab investigation, showing a notably elevated level of creatinine phosphokinase (906 u/L). Further clinical examination revealed proximal muscle weakness, winging of scapula and Bilateral LMN facial palsy. Therefore, the patient was ultimately directed to a neurologist who confirmed the diagnosis of limb-girdle muscular dystrophy
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- A 22-year-old man who used to work eight hours a day sitting for a long time in an office
Key inclusion criteria (1 listed)
- experiencing lower back stiffness and a dull back pain
Key exclusion criteria (1 listed)
- diabetes, heart disease, or muscle disease. any history of previous falls, accidents, surgeries, hospitalizations, and he denied any significant past illnesses, or allergies.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| physical therapyultrasound and TENS for the back | Other | – |
Primary outcome
An MRI of the lumbar spine
Time frame: one month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Mar 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Muscle Weakness
Not yet recruiting
"CORE Training for Musculoskeletal Health: A Study on Adaptive Exercise Protocols"
Core Muscle Weakness, Postural Control Deficit
Recruiting
rTMS for Postoperative Brain Tumor Patients
Brain Tumors, Transcranial Magnetic Stimulation
RecruitingObservational study
Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
IBM, Inclusion Body Myositis
Recruiting
Blood Flow Restriction Training in Knee Arthropathy
Knee Arthroscopic Surgery, Arthrogenic Muscle Inhibition
Not yet recruiting
Recurrent Laryngeal Nerve Monitoring During Pediatric Aerodigestive Tract and Cardiac Surgery
Unilateral Vocal Cord Paralysis, Unilateral Vocal Cord Paresis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Muscle Weakness, run by Noha Khaled Shoukry at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
An MRI of the lumbar spine (time frame: one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2025.